Week beginning 1st February 2021
News and media
USA Eleven different ME/CFS organizations co-sign a letter to congress recommending where to direct research funding provided by the federal COVID-19 economic relief package.
Letter
here Thread
here
Emerge Australia has launched an online service, with facilitated community groups for patients, carers and others, and an ME/CFS community forum.
Details
here Thread
here
Norway Opinion piece by Nina E. Steinkopf in the Journal for the Norwegian Psychologist Association about NICE's guideline draft where GET/CBT have been removed as treatment approaches. She appeals to Norwegian health authorities to keep up with the new developments.
Article
here Thread
here
Australia - ABC radio "Is society getting better at understanding people living with invisible illness?" features excellent input from Heidi and Simone from Emerge Australia, and unhelpful comments from a doctor.
Podcast
here (duration 51 minutes) Thread
here
...................
Books
Marcus Sedgwick, prizewinning author of adult and young adult fiction, has had ME/CFS for 7 years and has written a book about his experiences, 'All in Your Head', and is creating a podcast series.
Article
here Thread
here
Josie George Guardian article "‘My personal lockdown has been much longer’: on chronic illness, before and after Covid" by Josie George who has ME. She describes her life with ME and how lockdown has affected it very little. She has a forthcoming book: A Still Life: A Memoir by Josie George is published by Bloomsbury on 18 February.
Article
here Thread
here
Tracie White and Ron Davis Zoom event Friday February 12th.
Conversation with the author of the book 'The Puzzle Solver', Tracie White with Ron Davis and Janet Dafoe, facilitated by Rivka Solomon.
Details
here Thread
here
.....................
Research news
Cochrane
"Notification of a serious error in reviews Exercise therapy for chronic fatigue syndrome and CBT for chronic fatigue syndrome: resubmission"
Caroline Struthers has sent another letter to Cochrane, highlighting that the review on exercise therapy and the one on cognitive-behavioural therapy for ME/CFS contain serious errors that might lead to patients being harmed. Struthers argues that these reviews should be withdrawn.
Article and Thread
here
NIH Further reporting on the news (reported last week) that NIH has launched two online digital resources for ME researchers to access data from multi-omic studies (mapMECFS) and biospecimens as well as clinical information on patients (searchMECFS). In the column "Director's Messages" NIH states: "We encourage investigators from a variety of disciplines and interests to use these tools to pursue new research avenues. Our sincere hope is that these ME/CFS tools will also benefit the larger research community. It will take a large-scale effort – from all of us – to help find critical answers to this devastating disease."
Press release
here
Director's messages
here
Coverage by GEN (Genetic Engineering & Biotechnology News)
here
Thread
here
.....................
Biomedical research
Pharmacological Research
"ME/CFS: Where Will the Drugs Come From?" by Toogood et al.
The authors 'review the current understanding, diagnosis and treatment of ME/CFS and summarize past clinical studies aimed at identifying effective therapies.' Treatment targets include autoimmunity, immune dysregulation, eg N-K cell function, and mitochondrial dysfunction. They conclude with the need for more investment in research.
Article
here ME Association article by Charles Shepherd
here Thread
here
Clinical Neurophysiology
"Chronic fatigue syndrome: Abnormally fast muscle fiber conduction in the membranes of motor units at a low-level static force load" by Klaver-Krol et al.
Females with CFS (n=25), with FM (n=22), and healthy controls (n=21) underwent surface electromyography of the biceps. In the CFS patients, muscle conduction increased abnormally with force. The healthy controls it increased slightly and in FM not at all. The authors conclude 'Our results suggest disturbed membrane function in CFS patients, in their motor units involved in low force generation. Central neural deregulation may contribute to these findings.'
Paper
here Thread
here
Fatigue, Biomedicine, Health and Behavior
"Antibody-dependent cell-mediated cytotoxicity (ADCC) in familial ME/CFS" by Sung et al.
The authors explain that antibody-dependent cell-mediated cytotoxicity (ADCC) by NK lymphocytes helps control viral infections. Testing 5 families with more than one person with CFS (Fukuda), and healthy unrelated controls showed some differences.
'CFS patients
and their family members had fewer CD16Apositive NK cells, required more antibody, and had ADCC that was lower than the unrelated controls. CFS family members were predominantly genetically CD16A F/F s for the variant with low affinity for antibodies.'
They conclude: 'Low ADCC may be a risk factor for familial CFS. Furthermore, characterization of familial CFS represents an opportunity to identify pathogenic mechanisms of CFS.'
Article
here Thread
here
MedRxiv preprint
"A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses" by Comella et al.
15 people with CFS and 15 controls.
From the abstract: 'The immune cell type specific molecular signatures of CFS we identified, overlapped molecular signatures from other fatiguing illnesses [Covid, Lyme], demonstrating a common molecular etiology. Further, after constructing a probabilistic causal model of the CFS gene expression data, we identified master regulator genes modulating network states associated with CFS, suggesting potential therapeutic targets for CFS.'
Article
here Thread
here
Journal of Translational Medicine
"Off label use of Aripiprazole shows promise as a treatment for ME/CFS: a retrospective study of 101 patients treated with a low dose of Aripiprazole" by Bonilla et al.
On the basis of some evidence of neuroinflammation in ME/CFS, the doctors at the Stanford University ME/CFS clinic speculated that dopamine-modulating drugs like aripiprazole may lead to clinical improvement in fatigue and cognitive symptoms in ME/CFS. Patients at the clinic were prescribed varied low doses of the drug off label. This article takes a retrospective look at their clinical records. Some patients improved on subjective symptom severity questionnaires, some worsened or had to stop due to side effects. The authors conclude this is sufficient indication that a clinical trial is warranted.
Article
here Thread
here
Brain and Behavior
"Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in ME/CFS" by Haghighi et al.
This Swedish 12 week trial was set up to investigate the safety and tolerability of the drug with 33 patients. 28 completed the trial. The abstract concludes: '(‐)‐OSU6162 is well tolerated in ME/CFS patients and shows promise as a novel treatment to mitigate fatigue and improve mood and health‐related quality of life in ME/CFS. Obviously, the present results need to be confirmed in future placebo‐controlled double‐blind trials.'
Paper
here Thread
here
.......................
Other research
BMJ Open
“Exploratory study into the relationship between the symptoms of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) and fibromyalgia (FM) using a quasiexperimental design” by Mckay et al.
In this survey, the authors handed out fatigue and other symptom questionnaires to a group of ME/CFS and a group of fibromyalgia patients and concluded that there were few differences between the two groups.
Article
here Thread
here
Healthcare
“Experiences of Living with Severe CFS/ME” by Strassheim et al.
In this study, the authors conducted interviews with 5 individuals living with CFS/ME in its most severe form.
Article
here Thread
here
Journal of Mental Health
“Concern for Covid-19 cough, fever and impact on mental health. What about risk of Somatic Symptom Disorder?” by Willis & Chalder
In this editorial, the authors speculate that the COVID-19 and pandemic-related distress may lead to an increase of cases with Somatic Symptom Disorder.
Article
here Thread
here
Frontiers in Medicine
“Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With ME/CFS” van Campen et al.
In this study, the Dutch authors measured pain, fatigue and concentration difficulties for a period of up to 7 days after head-up tilt testing. While the symptom score increased slightly in the ME/CFS group (with or without fibromyalgia) it remained flat around zero in healthy controls.
Article
here Thread
here
.......................
Covid-19 and ME
Zebra Psych "I'd rather die than be sick for a year"
Wise reflection's from Louise Kenward on society's estranged views on illnesses and its "othering" of disabled people.
Article
here Thread
here
Podcast Long Covid Physio: "Long Covid Rehab Research"
Interesting conversation between Long Covid Physio Darren Brown and postdoc fellow Simon Décary. Décarey tells of how listening to patients and by familiarising himself with ME and PEM, took his research project on Long Covid and rehabilitation in a completely new direction with #StopRestPace as principle. Duration: 1 H 3 min.
Thread with episode as YouTube video
here
TNR (The New Republic) "The Forever Disease: How Covid-19 Became a Chronic Condition"
A thorough and informative long read on Long Covid, ME, and the importance of further knowledge and research into post virus illness. Article is also available as audio version.
Article
here Thread
here
Blog "Professor Garner, The BMJ and me: an alarming flip-flop on recovery from long Covid"
Valerie Eliot Smith, in an excellent article, reviews Professor Paul Garner's series of articles in BMJ Opinion (see last week's news), and discusses her correspondence with him. 'Professor Garner’s post of 25 January 2021 demonstrates an extraordinary lack of empathy for a patient community with which he had previously identified so strongly. As to what caused such a profound and damaging
volte-face, one can only speculate.'
Article
here Thread
here
Other items of interest
RNZ "Covid long haulers fighting to be heard"
Article
here Thread
here
The New York Times "Long-Haul Covid and the Chronic Illness Debate"
Article
here Thread
here
Dagens Medicin "Vården av långtidssjuka i covid måste säkerställas" Appeal by Swedish politician Catarina Wahlgren on securing care for patients with Long Covid and with ME.
Article
here Thread
here
ZDF "Immer erschöpft - Das Fatigue Syndrome" 6 minute TV news segment from Germany on Covid-19 and ME.
Video
here Thread
here
NIH - The Schor Line "Working together to understand long-term effects of Covid-19"
Article
here Thread
here
.......................
S4ME social media:
Facebook,
Twitter and
You Tube